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PRiMA: The Membrane Anchor
of Acetylcholinesterase in the Brain
gomers. BChE exists as a single type of catalytic sub-
unit, corresponding to the AChET variant and can be
found in a similar multitude of molecular forms (Blong
Anselme L. Perrier, Jean Massoulie´,
and Eric Krejci1
Laboratoire de Neurobiologie Cellulaire
et Mole´culaire et al., 1997).
CNRS UMR 8544 The collagen-tailed forms of AChE or BChE contain
Ecole Normale Supe´rieure a specific collagen subunit, ColQ, which anchors them
46 rue d’Ulm in the extracellular matrix of the neuromuscular junction
75230 Paris Cedex 05 (Krejci et al., 1997). The N-terminal domain of ColQ con-
France tains a short PRAD (proline-rich attachment domain)
(Bon et al., 1997). We have shown previously that the
PRAD of ColQ organizes AChET subunits into a tetramer
via interaction with the C-terminal domain of AChET sub-Summary
unit, also called the tryptophan amphiphilic tetrameriza-
tion (WAT) domain (Simon et al., 1998). This tetramericAs a tetramer, acetylcholinesterase (AChE) is an-
molecular complex can also be assembled in vitro bychored to the basal lamina of the neuromuscular junc-
incubation of purified AChET with a PRAD peptide (Kron-tion and to the membrane of neuronal synapses. We
man et al., 2000). Inactivation of the ColQ gene in micehave previously shown that collagen Q (ColQ) anchors
by homologous recombination eliminates all AChE fromAChE at the neuromuscular junction. We have now
neuromuscular junctions. This demonstrates that thecloned the gene PRiMA (proline-rich membrane an-
formation of AChE-ColQ heterooligomers is determinantchor) encoding the AChE anchor in mammalian brain.
for AChE localization and function at the neuromuscularWe show that PRiMA is able to organize AChE into
junction. However, in ColQ/ mice, BChE remains pres-tetramers and to anchor them at the surface of trans-
ent in its membrane-bound form at the neuromuscularfected cells. Furthermore, we demonstrate that AChE
is actually anchored in neural cell membranes through junction, as does membrane-bound AChE in the brain,
its interaction with PRiMA. Finally, we propose that demonstrating that membrane-bound tetramers of AChE
only PRiMA anchors AChE in mammalian brain and and BChE do not depend upon the PRAD of ColQ for
muscle cell membranes. localization or formation of tetramers (Feng et al., 1999).
The predominant form of AChE in the brain is a tetra-
mer that interacts with detergent and contains a 20 kDaIntroduction
hydrophobic subunit (Gennari et al., 1987; Inestrosa et
al., 1987) covalently linked by disulfide bonds to cys-The two related enzymes, acetylcholinesterase (AChE)
teines of AChE (Roberts et al., 1991). This suggests thatand butyrylcholinesterase (BChE), hydrolyze acetylcho-
this protein, called the P subunit (Massoulie´ et al., 1993),line in mammals, thereby regulating cholinergic stimula-
serves to anchor AChE in cell membranes like ColQtion. An excess of acetylcholine is toxic, and poisoning
anchors AChE in the basal lamina. Biochemical analysesby cholinesterase inhibitors, such as insecticides (Fey-
of the membrane-bound form of bovine brain AChE haveereisen, 1995) or nerve gases, produces various symp-
led to the determination of the N-terminal sequence andtoms ranging from local necrotic myopathy to respira-
of several internal peptide sequences (Boschetti andtory paralysis and death (Leonard and Salpeter, 1979).
Brodbeck, 1996; Perrier et al., 2000). All but one of theseHowever, controlled treatment with cholinesterase in-
internal peptides map to the protein mCutA (Navaratnamhibitors is used to help patients suffering of myasthenia
et al., 2000). We have shown that since mCutA does notgravis and Alzheimer’s disease (Giacobini, 2000).
interact with AChE and is not disulfide-linked to AChET,At the molecular level, AChE and BChE are found in
it cannot be the P subunit (Perrier et al., 2000). We havea number of forms, depending, in the case of AChE, on
also demonstrated that the peptide sequence, whichalternative splicing and association with noncatalytic
did not correspond to mCutA, contains an epitope ofproteins (Massoulie´ et al., 1993). The splice variants of
AChE possess the same catalytic domain but differ in the 20 kDa P subunit of bovine brain AChE (Perrier et
small C-terminal domains (Massoulie´ et al., 1998). The al., 2000).
AChER variant produces a soluble monomer which is We now report the molecular and genetic structure
upregulated in the brain during stress (Kaufer et al., of the P subunit in mice and humans, which we now
1998); the AChEH variant produces a GPI-anchored di- call PRiMA (proline-rich membrane anchor). We show
mer which is mainly expressed in blood cells in mam- that PRiMA is sufficient to target AChE to the cell sur-
mals (Li et al., 1991); the AChET variant, the only type of face. PRiMA, like ColQ, contains a functional PRAD do-
catalytic subunit expressed in the brain and muscles of main, an organizer of AChE and BChE tetramers. In
adult mammals (Legay et al., 1995), produces various neuroblastoma cells, PRiMA is a limiting factor in the
oligomers including monomers, dimers, and tetramers, targeting of AChE to the membrane. Finally, we estab-
as well as collagen- and hydrophobic-tailed heterooli- lished that PRiMA organizes and anchors most mem-
brane-bound tetramers of cholinesterase in brain and
muscle.1 Correspondence: krejci@wotan.ens.fr
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Figure 1. Structure and Characterization of
PRiMA
(A) Partial genomic map of human chromo-
some 14 indicating the positions of BACs
AL132642 and AL157858 (reverse orientation)
in the region encoding PRiMA. In the exon/
intron structure of the PRiMA gene, the five
exons are represented to scale by open
boxes (noncoding) and shaded boxes (coding
region). The initiation codon for translation
(ATG) and the stop codon (STOP) are indi-
cated. Polyadenylation sites are indicated by
asterisks (*).
(B) Predicted peptidic sequences of mouse
and human PRiMA, deduced from the cDNA
(mouse) and from the genomic sequence (hu-
man); the complete primary sequence is shown
for mouse PRiMA, only the differences are
specified for human PRiMA. The underlined
peptide corresponds to the reported N-terminal
and doubly underlined peptides to internal
sequences of the 20 kDa protein. The pre-
dicted signal peptide is shown in italics and
the predicted transmembrane domain in bold
characters.
(C) Schematic representation of the predicted
regions of PRiMA shows the N-terminal signal
peptide (fine lane), the extracellular domain
(ECD) that contains five cysteines (c), a pro-
line-rich sequence (PRAD) and putative
N- and O-glycosylation sites, the predicted
transmembrane region (TMD), and the C-ter-
minal cytoplasmic domain (CD). The cyto-
plasmic domain contains a cysteine (c) at the
border of the transmembrane region and pu-
tative phosphorylation sites on serines (s).
(D) Analysis of purified bovine brain AChE by
SDS gel electrophoresis. Lane 1, protein
staining of a reduced sample; the major band
(70 kDa) represents the AChE monomeric
subunit. Lanes 2 and 3, Western blot with an
immune serum against a GST-PRiMA fusion
protein; lane 2, after reduction, the antibodies
label a 20 kDa protein and a weak band corre-
sponding to the 20 kDa associated with an
AChE monomer; lane 3, without reduction, the labeling at 20 kDa is absent, and all the labeling is associated with high-molecular species.
(E) Northern blot analysis of PRiMA transcripts in mouse tissues. The different lanes correspond to 2 g poly-A RNA from heart, brain,
spleen, lung, liver, skeletal muscle, kidney, and testis hybridized with a probe corresponding to the coding sequence of PRiMA.
Results rameric form of AChE (Lazar and Vigny, 1980; Perrier et
al., 2000).
The resulting 0.9 kb mouse cDNA contains a singlecDNA and the Gene Encoding PRiMA, a 20 kDa
Protein Covalently Associated with AChE open reading frame encoding PRiMA. The deduced
amino acid sequences of mouse and human PRiMAThe AChE-associated 20 kDa protein was previously
purified from bovine brain, and the N-terminal sequence are very similar, with 90.9% identity (93.5% homology)
(Figure 1B). The primary structure of PRiMA containsEPQKSCSKYTD and an internal peptide sequence
GVDANSAVEYPMT were obtained by chemical se- four distinct regions (Figure 1C): a putative signal pep-
tide, followed by the reported N-terminal peptide se-quencing (Boschetti and Brodbeck, 1996; Perrier et al.,
2000). Polyclonal antibodies (G13T) raised against the quence (Boschetti and Brodbeck, 1996; Perrier et al.,
2000), and putative extracellular, transmembrane, andinternal peptide were shown to recognize the AChE-
associated 20 kDa protein (Perrier et al., 2000). With cytoplasmic domains. PRiMA contains two putative
O-glycosylation sites (S74 and T81) and a putative N-glyco-these peptides as a query, we performed a tblastn
search and found a human genomic sequence con- sylation site (N79), in agreement with the fact that the
20 kDa anchor protein is N glycosylated (Boschetti andtaining the N-terminal but not the internal peptide se-
quence. With primers designed from this genomic se- Brodbeck, 1996).
The absence of the internal peptide sequence in thequence (Figure 1A), we generated partial mouse cDNA
clones by 5 and 3 RACE (Frohman, 1993). As a tem- mouse cDNA does not result from alternative splicing
(see below); in fact, it appears likely that this chemicallyplate, we used mRNA from differentiated N18TG2 neuro-
blastoma cells, which express the membrane-bound tet- determined sequence results from a combination of two
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different tryptic peptides of PRiMA (doubly underlined
sequences in Figure 1B). To examine more directly the
relationship between PRiMA and AChE in the mamma-
lian brain, we generated an immune serum against a
GST fusion protein containing the C terminus of PRiMA
and performed Western blots with purified brain AChE.
Protein staining of a reduced sample on SDS-polyacryl-
amide gel (Figure 1D, lane 1) showed a major band
corresponding to the AChE catalytic subunit (70 kDa).
Anti-PRiMA antibodies revealed mostly a diffuse band
around 20 kDa (Figure 1D, lane 2) and also a weak 90
kDa band, indicating that the corresponding complex
contained PRiMA. Without reduction (Figure 1D, lane 3),
the 20 kDa band was not observed, but the anti-PRiMA
antiserum reacted with several bands corresponding to
dimers (140 kDa) and higher oligomers of AChE. This
pattern is similar to that previously reported with the
polyclonal antiserum G13T, which recognizes the P sub-
unit (Perrier et al., 2000), as well as with the monoclonal
antibody 132-6, which recognizes the P subunit when
it is disulfide linked to AChE catalytic subunits (Liao et
al., 1993a). This demonstrates that PRiMA is a 20 kDa
protein, which is associated through disulfide bonds
with AChE, in bovine brain. Figure 2. PRiMA Targets AChET to the Cell Surface
We analyzed PRiMA transcripts by Northern blotting, (A) The green fluorescent protein identifies transfected cells; non-
RT-PCR, and a blast search of EST databases. Northern permeabilized COS cells were stained with rhodaminated fasciculin
to reveal cell surface AChE. (a and b) COS cells expressing GFPblots showed that a 3.3 kb transcript is expressed in
and AChET without PRiMA. (c and d) COS cells expressing GFP andbrain, heart, muscle, and kidney (Figure 1E). In kidney,
AChET with PRiMA. AChE was only detected on the cell surfacewe also observed an 0.9 kb transcript that may corre-
when coexpressed with PRiMA.spond to the short cDNA that we cloned. In testis, we
(B) Extracellular AChE activity of coinjected oocytes. Xenopus oo-
observed a 1.1 kb transcript. The 3.3, 1.1, and 0.9 kb cytes were injected with RNA encoding AChE, AChE and mCutA,
transcripts probably differ only in their 3 noncoding or AChE and PRiMA. AChE activity was measured on living oocytes;
the values are means of independent oocytes, with standard devia-regions by the use of different polyadenylation sites
tions. AChE was only present on the surface when AChE was coex-(Figure 1A, asterisks), they contain the same coding
pressed with PRiMA.sequence and are therefore predicted to encode the
same PRiMA protein. As many as 64 ESTs (32 for mouse
and 32 for human) correspond to the longer murine 3.3
the cell surface of the transfected cells (Figures 2Aakb transcript or its 3.7 kb human equivalent, with only
and 2Ab, COS cells), as previously reported (Bon and5 ESTs extending into part of the coding sequence. Most
Massoulie´, 1997). Similarly, cell surface AChE activityESTs were derived from brain, in agreement with the
was not detectable in Xenopus oocytes after injectionidea that the PRiMA gene is mainly expressed in the
with AChET mRNA or with AChET and mCutA mRNAscentral nervous system.
(Figure 2B). In contrast, when AChET was expressedThe PRiMA gene is located on human chromosome
with PRiMA, we observed a clear and uniform labeling14 (14q32.12), 93.7 Mb from the centromere, in reverse
of AChE with rhodaminated fasciculin at the surface oforientation (Figure 1A). Analysis of this region shows
transfected COS cells (Figures 2Ac and 2Ad) or undiffer-that this gene spans approximately 70 kb and that the
entiated N18TG2 cells (data not shown), as well as amRNA consists of a 5 noncoding exon and four coding
clear detection of cell surface AChE activity on livingexons; the last of which contains the long 3 noncoding
oocytes (Figure 2B).sequence. To date, this locus has not been associated
with any pathology.
PRiMA Is a Type I Transmembrane Protein
Biochemical studies have proposed that fatty acylationPRiMA Targets AChE to Plasma Membranes
We expressed AChET, with or without PRiMA, in various is responsible for the hydrophobicity of the 20 kDa
AChE-associated protein (Fuentes et al., 1988). The pri-cell lines and in Xenopus oocytes, which produce little or
no endogenous AChE. In mammalian cells, transfected mary organization of PRiMA suggests that the hy-
drophobic segment (92–113) represents a transmem-cells were identified by the expression of GFP, and ex-
tracellular AChE was stained with rhodaminated fasci- brane domain that seems sufficient to confer membrane
anchoring. However, the C-terminal border of this do-culin, a venom toxin with high affinity for AChE (Karlsson
et al., 1984; Peng et al., 1999). In oocytes, cell surface main contains a putative site for fatty acylation, cysteine
114 (C114) (Resh, 1999). We tested whether C114 isAChE activity was directly quantified by incubating indi-
vidual oocytes in the assay medium. When an AChET necessary to target AChE to the plasma membrane.
The mutation of cysteine 114 to alanine (C114A) did notcDNA was transfected alone in COS cells or in undiffer-
entiated N18TG2 cells, the enzyme was not exposed on modify the localization of PRiMA-associated AChE on
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still localized at the cell surface (Figure 3Ac), indicating
that plasma membrane targeting of PRiMA does not
require its association with AChET.
After cotransfection with AChET and PRiMA-MYC,
nonpermeabilized cells were labeled by fasciculin but
not by anti-MYC antibodies (Figures 3Ba and 3Bb),
whereas the permeabilized cells were labeled by anti-
MYC antibodies (Figure 3Bc). Thus, the C terminus of
PRiMA is intracellular.
We then deleted the cytoplasmic C-terminal domain of
PRiMA (amino-acids 122–153). Coexpression of AChET
with this deleted construct produced AChE at the cell
surface (data not shown) as with the complete PRiMA
protein. Thus, the C-terminal domain of PRiMA is not
necessary for anchoring AChE to the cell membrane.
These results show that PRiMA is a type I transmem-
brane protein, sufficient for its own plasma membrane
targeting and necessary for plasma membrane targeting
of AChET.
The Extracellular Domain of PRiMA Contains a PRAD
Organizer of AChE and BChE Tetramers
Figure 3. PRiMA Is a Type I Transmembrane Protein To examine whether PRiMA organizes tetramers of
(A) Expression of PRiMA carrying N-terminal FLAG epitope (FLAG- AChE subunits, we expressed AChET with or withoutPRiMA) in undifferentiated N18TG2 cells. (a and b) Nonpermeabil-
PRiMA in Xenopus oocytes. This system produces onlyized cells coexpressing AChET and FLAG-PRiMA were labeled with
AChE monomers when AChET is expressed alone at lowrhodaminated-fasciculin (a) and with anti-FLAG M1 antibodies (b),
mRNA concentrations (Figure 4Aa). The expression ofrevealing the presence of both AChE and PRiMA, colocalized on
the cell surface (examples are indicated by arrows). Nonpermeabil- AChET and PRiMA results in the production of a 10S
ized cells expressing FLAG-PRiMA alone are visualized with anti- form (tetramer). This 10S species is amphiphilic because
FLAG M1 antibodies (c); there was no labeling of AChE with fasci- its sedimentation is slower in the presence of Brij-97
culin (data not shown).
than in the presence of Triton X-100 (Figure 4Ab), as(B) Expression of PRiMA carrying C-terminal MYC epitope (PRiMA-
expected for a membrane-anchored protein. It was im-MYC) in undifferentiated N18TG2 cells. (a and b) Nonpermeabilized
munodepleted after incubation of cell extracts with ancells coexpressing AChET and PRiMA-MYC were labeled with rho-
daminated-fasciculin (a) but not with anti-MYC antibodies (b), re- anti-GST-PRiMA serum, but not with the preimmune
vealing that AChE was present at the cell surface but not the C serum, while monomeric AChE was not affected (Figure
terminus of PRiMA. Permeabilized cells expressing PRiMA-MYC 4Ac). These results demonstrate that cotransfected cells
were labeled with anti-MYC antibodies (c).
produced PRiMA-anchored membrane-bound tetra-
mers of AChE.
The extracellular domain of the mature PRiMA protein
contains a proline-rich motif (positions 56–70), whichthe cell surface (data not shown). Thus, acylation of
C114, if it exists, is not required for the externalization is similar to the proline-rich motif of ColQ (PRAD), the
domain that interacts with AChE (Bon et al., 1997). Inand membrane association of PriMA-associated AChE
tetramers. PRiMA, this motif consists of two stretches of four and
ten prolines, followed by two leucine residues. In undif-The presence of a signal peptide and a hydrophobic
domain in PRiMA suggested that the N-terminal is extra- ferentiated N18TG2 cells, FLAG-PRiMA with the entire
proline-rich motif deleted was targeted to the plasmacellular and the C-terminal intracellular. To experimen-
tally define this topology, we inserted a FLAG epitope membrane, but it did not associate with AChE, as shown
by labeling with M1 antibodies and absence of staining(DYKDE) between the putative signal peptide and the N
terminus of the mature PRiMA protein (position 36) or with fasciculin (Figures 4Ba and 4Bb). To demonstrate
that the N terminus of PRiMA contains an AChE bindinga MYC epitope at the C terminus of PRiMA. Anti-FLAG or
anti-MYC antibodies immunoprecipitated AChE activity motif, we fused the signal peptide and the proline-rich
motif (position 1–79) to a GPI addition sequence, asfrom extracts of cells transfected with AChET and FLAG-
PRiMA or PRiMA-MYC. In both cases, the epitope was previously done to analyze the proline-rich motif of ColQ
(Duval et al., 1992). In undifferentiated N18TG2 cells,maintained and accessible for the antibodies in the ma-
ture complex. coexpression of this construct with AChET produced
membrane-bound AChE (Figure 4Bc). Furthermore,When AChET was expressed with the FLAG-PRiMA
construct, immunostaining of nonpermeabilized cells analysis of the AChE molecular forms produced by oo-
cytes coexpressing AChE with this construct showedwith an anti-FLAG monoclonal antibody (M1) showed
that PRiMA was present at the surface of the transfected that the proline-rich motif of PRiMA, like that of ColQ,
organized an amphiphilic tetramer of AChE catalyticcells like AChE (Figures 3Aa and 3Ab). The M1 labeling
demonstrates that the N-terminal region of PRiMA is subunits (Figure 4Bd). Thus, the proline-rich region of
PRiMA organizes AChE tetramers. We expressed BChEextracellular and colocalized with AChE. Interestingly,
when PRiMA was expressed alone, we found that it was with and without PRiMA in COS cells to test whether
AChE Membrane Anchor
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PRiMA can also interact with BChE. The sedimentation
profile of molecular forms produced by cells coexpress-
ing BChE with PRiMA contained a major component at
9.8S in the presence of Brij-97 (data not shown). This
corresponds to amphiphilic tetramers of BChE, similar
to the membrane-bound AChE tetramers extracted from
Xenopus oocytes.
In the case of ColQ, the proline-rich motif organizes
AChE tetramers through the association of one proline-
rich motif (PRAD) with four C-terminal domains of AChET
(WAT domain), independent of the disulfide bond (Simon
et al., 1998). The mutation in AChE of the C-terminal
cysteine C572 into a serine does not prevent the organi-
zation of tetramers (Figure 4Ca). The deletion of the
WAT domain of AChET suppresses the organization of
tetramers (Figure 4Cb) and blocks the targeting of AChE
by PRiMA to the cell surface (data not shown). When
the catalytic domain was replaced by a FLAG epitope
(FLAG-WAT) and was expressed alone in cells, it was
not addressed to the surface (Simon et al., 1998). In
contrast, when coexpressed with PRiMA, it was targeted
to the cell surface, as revealed by the labeling by M1
antibodies of nonpermeabilized cells (Figure 4Cc). This
established that the C-terminal domain of AChET is nec-
essary and sufficient for the interaction of AChET with
PRiMA.
Taken together, these results strongly suggest that
the quaternary associations of AChET with PRiMA and
with ColQ are similar; therefore, the proline-rich se-
quence of PRiMA is a novel PRAD that interacts with
four C-terminal domains (WAT domains) of AChE.
PRiMA but Not mCutA Anchors AChE
on the Surface of Neuroblastoma Cells
We used neuroblastoma cells N18TG2 to examine the
targeting of AChE to the cell surface. During exponential
growth or stationary phase in the presence of serum
(undifferentiated cells), we were unable to detect the
presence of AChE at the cell surface by immunostaining
Figure 4. PRiMA Contains a PRAD that Organizes Tetramers of with antibodies raised against rat AChE (A63) (Figure
AChe through Its C-Terminal Domain 5Aa), although these cells do produce AChE. When 2%
(A) (a and b) Sedimentation profiles of AChE activity in extracts of DMSO was added to the culture medium (N18TG2 cells
Xenopus oocytes expressing AChET without PRiMA (a) and with were induced to differentiate within 4–6 days), the cellsPRiMA (b). Each extract was analyzed in sucrose gradients con-
stopped dividing and moderately extended neurites.taining Triton X-100 or Brij-97, as indicated. The shift of the peak
During this period, the cells produced membrane-boundrevealed the amphiphilic character of AChE forms. The different
molecular forms are schematically represented above each peak; AChE, exposed on their surface (Perrier et al., 2000), as
AChE subunits are represented as white circles and PRiMA as a revealed by immunostaining (Figure 5Ab). We analyzed
shaded rectangle. Sedimentation profile of AChE activity in an ex- by Northern blot and RT-PCR the relative levels of
tract of Xenopus oocytes expressing AChET and PRiMA in sucrose mRNAs encoding AChE, PRiMA, and mCutA (Figuregradients containing Brij-97, immunodepleted by a preimmune se-
5Ac). During differentiation, we observed an increase inrum (closed circles) or by anti-PRiMA serum (open circles) (c).
AChE mRNA in agreement with a 10-fold increase in(B) PRAD is necessary and sufficient for association of PRiMA with
AChE. (a and b) Nonpermeabilized cells coexpressing AChET and
PRiMA-PRAD were labeled with anti-FLAG M1 antibodies (a) but
not with rhodaminated-fasciculin (b), revealing the presence PRiMA-
PRAD without AChE on their surface. Nonpermeabilized cells AChE activity in extracts from COS cells expressing AChET (C572S)
coexpressing AChET and PRAD-GPI (a construct in which the extra- (closed circles) with PRiMA (a). Cell extracts were analyzed in Brij-
cellular domain of PRIMA was fused to a GPI addition signal) were 97-containing gradients; the different molecular forms are schemati-
labeled with rhodaminated-fasciculin (c). Sedimentation profiles of cally represented above each peak. Sedimentation profiles of AChE
AChE activity in extracts from Xenopus oocytes expressing AChET activity in extracts from COS cells expressing AChE-WAT (deletion
with PRAD-GPI (closed circles) or alone (open squares) (d). Cell of the C-terminal domain) with PRiMA (open squares) (b). The cells
extracts were analyzed in Triton X-100 containing gradients; the produce only monomer. Undifferentiated N18TG2 cells were trans-
different molecular forms are schematically represented above each fected with PRiMA and FLAG-WAT (c). Nonpermeabilized cells were
peak. labeled with anti-FLAG M1 antibodies. The C-terminal domain of
(C) The C-terminal domain of AChET (WAT domain) is necessary and AChET domain was targeted to the cell surface like the full-length
sufficient for association with PRiMA. Sedimentation profiles of AChET.
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Figure 5. PRiMA Is the Limiting Factor for
Membrane Anchoring of AChE in N18TG2
Cells
(A) (a and b) AChE was detected by a fine
immunostaining on the surface of nonperme-
abilized-differentiated N18TG2 cells (b) but
not on the surface of undifferentiated N18TG2
cells (a). Detection of AChE, mCutA, and
PRiMA transcripts by Northern blot and RT-
PCR in undifferentiated (ud) and in differenti-
ated (d) cells (c).
(B) Transfection of differentiated N18TG2
cells with PRiMA-enhanced AChE staining
(a). Right panels, the stably transfected
N18TG2 expressing an antisense-PRIMA
construct were identified by GFP (white
arrows in [b]). These cells were mixed with
nontransfected N18TG2 cells in differentia-
tion medium. Differentiated cells expressing
the PRiMA antisense vector exposed less
AChE on their membrane (white arrows, [c]).
(C) The N18TG2 “mCutA-antisense” cell line
was differentiated in DMSO and immuno-
stained for AChE cell surface. Nontransfected
cells do not express AChE on the cell surface
(a). The cotransfected cells with AChE and
PRiMA exposed AChE as shown by the
strong immunostaining (b).
AChE activity. mCutA mRNA was expressed at similar PRiMA Anchors AChE in Mouse Brain and Both
AChE and BChE in Muscleslevels before and after differentiation, whereas PRiMA
was undetectable by Northern blot at any stage. By RT- Does PRiMA anchor cholinesterase tetramers to cell
membranes in vivo? To address this question, we ex-PCR, PRiMA mRNA was detected in differentiated, but
not in undifferentiated, cells. tracted cholinesterases from brain and skeletal muscle
in the absence of detergent and then with detergent andWe found that AChE labeling on the membrane was
enhanced by overexpression of exogenous PRiMA in performed immunodepletion of detergent extracts with
an anti-PRiMA serum. In sedimentation profiles ob-differentiated N18TG2 cells (Figure 5Ba). Conversely,
AChE labeling was suppressed when the expression of tained in the presence of detergent Brij-97, tetramers
of AChE and BChE correspond to 9S and 9.8S peaksPRiMA was blocked in cells transfected with PRiMA
antisense cDNA (Figures 5Bb and 5Bc). These results respectively. These peaks were markedly decreased
after immunodepletion with the anti-PRiMA serum butindicate that PRiMA is a limiting factor for localization
of AChE at the cell surface. not with the preimmune serum (Figure 6), whereas the
monomeric species (around 4S) were not depleted byThe “mCutA antisense” cell line, obtained by stable
expression of an antisense mCutA construct in N18TG2, the anti-PRiMA antiserum. These experiments demon-
strate that PRiMA is associated with most AChE tetra-did not expose AChE to the cell surface after differentia-
tion (Figure 5Ca), and the level of amphiphilic tetramer mers in detergent extracts from mouse brain and with
most AChE and BChE tetramers in detergent extractswas decreased (Perrier et al., 2000). When these cells
were transfected with PRiMA and AChET, they showed from skeletal muscle.
a high level of AChE on the surface (Figure 5Cb). Similar
results were obtained with transfection of PRiMA only Discussion
(data not shown).
These experiments on differentiated N18TG2 cells PRiMA, the Membrane Anchor of AChE,
Is a Type I Integral Membrane Proteindemonstrated that PRiMA is essential to the production
and the exposition of membrane-bound AChE, whereas that Possesses a PRAD
We showed that PRiMA represents the 20 kDa proteinmCutA is dispensable, at least when PRiMA is overex-
pressed. (P subunit), which is disulfide-linked to brain AChE. This
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Figure 6. PRiMA Expression in Mouse Tissues
Sedimentation profiles of AChE (a and b) and
BChE (c) in detergent extracts from mouse
brain (a), and skeletal muscle (b and c) in
sucrose gradients containing Brij-97 are shown.
The extracts were immunodepleted by a pre-
immune serum (closed circles) or with an anti-
serum raised against PRiMA (open squares).
Only tetramers of AChE and BChE (around
9S–10S) were immunodepleted.
protein is an integral membrane protein of type I, with entiation conditions, but not when membrane anchoring
is increased by overexpression of PRiMA.an N-terminal extracellular domain, a single transmem-
brane region, and a C-terminal cytoplasmic domain. We To date, no direct interaction has been established
between mCutA and PRiMA or AChE. We are currentlyestablished that PRiMA is able to organize AChE and
BChE tetramers and anchor them to plasma membranes investigating indirect interactions that may involve other
intracellular or membrane partners. In any case, PRiMAand that it localizes AChE to the cell surface in the
neuroblastoma cell line. Finally, we established that is the element that organizes AChE tetramers and tar-
gets them to the membrane, and mCutA is not absolutelyPRiMA is associated with AChE and BChE tetramers in
mouse brain and muscle cell membranes. required, especially when PRiMA is overexpressed.
The proline-rich motif of PRiMA appears to associate
with AChE in a very similar manner as the PRAD of Is There a Diversity of Cholinesterase Tetramers
ColQ. This motif therefore constitutes a novel example in Tissues and in Cell Cultures?
of PRAD, a domain that assembles with four C-terminal Overexpression of AChET in several cell lines or in Xeno-extensions of AChET (WAT). Although disulfide bonds pus oocytes can produce tetramers that are soluble in
are not required for the binding of AChE subunits to the medium and not anchored at the cell surface. These
PRiMA, SDS-PAGE analysis of nonreduced membrane- tetramers are also contained in intracellular compart-
bound AChE tetramers showed that the 20 kDa anchor ments so that their solubilization in cell extracts is im-
is associated with monomers, dimers, trimers, and tetra- proved with detergent; in addition, these tetramers may
mers (Liao et al., 1993b). In fact, the extracellular interact with detergent micelles and are therefore classi-
N-terminal domain of PRiMA, upstream of the PRAD, fied as amphiphilic tetramers (Bon and Massoulie´, 1997).
contains four cysteine residues that may form disulfide However, they are not exposed at the cell surface. Thus,
bonds with the C-terminal cysteine of AChET (Roberts contrary to a frequent misconception, the amphiphilic
et al., 1991), in the same way as two cysteine residues character of cholinesterase tetramers does not neces-
of ColQ are linked to an AChE dimer. sary imply that they are anchored in cell membranes;
similarly, Xenopus oocytes produce AChET monomers
mCutA Is Not Primarily Involved in the Anchoring which are amphiphilic (Figure 4Aa) but not exposed to
of AChE in the Membrane the cell surface (Figure 2B). In fact, only amphiphilic
The properties of PRiMA clearly distinguish it from the tetramers that contain PRiMA appear to possess this
protein mCutA, which was copurified with bovine brain property. We show that a large fraction of AChE and
AChE: mCutA is not disulfide-bound with the catalytic BChE tetramers extracted by detergent from mouse
subunit; and mCutA is not able to organize AChE or brain and muscle are associated with PRiMA. It is there-
BChE tetramers or to target AChE or BChE to the cell fore likely that PRiMA alone is responsible for anchoring
surface. However, our previous data suggested that cholinesterase tetramers in all plasma membranes, just
mCutA is required for AChE anchoring: both the produc-
tion of amphiphilic AChE tetramers and the localization
of the enzyme at the surface of differentiated N18TG2
cells were suppressed by transfection with an antisense
construct against mCutA (Perrier et al., 2000). In the
same cellular model, we now rescued the membrane
targeting of AChE by expression of PRiMA and AChE
or PRiMA alone.
We may interpret this result in different ways: (a) ex-
pression of an mCutA antisense construct may decrease
the expression of PRiMA and thus impair the targeting
of AChE to the cell surface so that it is restored by
overexpression of PriMA; (b) mCutA may help the inter-
action of AChE and PRiMA; the presence of mCutA
Figure 7. Schematic Model of the Organization and Membrane In-
would be necessary at low levels of PRiMA, but overex- sertion of the AChE-PRiMA Complex
pression of PRiMA would compensate for its absence;
The spheres represent the catalytic subunit and the depression the
and (c) mCutA may stabilize the PRiMA/AChE complex entrance of the catalytic gorge. PRiMA is shown as a black ribbon
at the cell surface, which would be necessary for AChE and the expansions between the catalytic tetramer and the mem-
brane correspond to the putative glycosylation motifs.to become detectable at the surface under normal differ-
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human ESTs by comparison of human genomic sequences with theas ColQ is responsible for the insertion of cholinester-
mouse cDNA sequence.ases into extracellular matrices (Feng et al., 1999).
The predictions of protein organization were performed at http://
www.expasy.ch/. O-glycosylation sites were identified through
http://www.cbs.dtu.dk/databases/OGLYCBASE/ (Gupta et al., 1999).Functional Localization of Cholinesterases
Site-directed mutagenesis was performed according to theby PRiMA
method of Kunkel et al. (1987) to construct point mutations, to insertThe main function of cholinesterases is to control the
a sequence encoding the FLAG epitope (DYKDE) at position 36
level of acetylcholine. This control depends not only (FLAG-PRiMA), or to delete amino acids 56–70 (mPRiMA  PRAD).
upon the catalytic properties of AChE and BChE but We used PCR to delete the C-terminal region 122–153 (mPRiMA 
also upon their localization relative to acetylcholine re- Cter) and to fuse the C-terminal of PRiMA (114–153) with glutathione
S-transferase (GST) into the pGEX-2T* vector (Amersham Phar-ceptors. PRiMA organizes AChE tetramers, which prob-
macia) at the EcoRI restriction site. We also used PCR to insert theably possess the quasi-square organization that was
PRiMA coding sequence (position 1–153) in frame with a six timeobserved for collagen-tailed tetramers (Bourne et al.,
repeated sequence of the MYC epitope (MEQKLISEEDLNE) followed
1999). Two catalytic gorges open toward one side of by a stop codon into the pCS2-6xMYC Tag vector. All constructs
the plane and the two others toward the other side. The were verified by sequencing. The constructions of AChE Delta WAT,
short sequence between the PRAD and the transmem- AChE (C572S) (Bon et al., 1997), and FLAG-WAT (Simon et al., 1998)
were previously described.brane domain suggests that the planar tetramer is ori-
Several human ESTs correspond to portions of intronic sequencesented parallel to the surface of the membrane and allow
within the PRiMA gene. Five ESTs (AI792859, AI7333951, AI733937,us to propose a model (Figure 7). This position may
AI254973, and AI254938) correspond to a short region of the geno-
also be influenced by the presence of N- and O-linked mic sequence between exons 2 and 3, which contains a small poly
glycans between the AChE attachment domain and the (A) sequence. These likely do not represent real ESTs but rather
transmembrane domain of PRiMA. The fatty acylation genomic fragments that have been amplified by the oligo-dT primer
during construction of the cDNA libraries. Two human ESTs,and O-glycosylation of PRiMA could direct the heterooli-
(AA814693, 1.6 kb long, and BF355282) originate from the introngomers to specific membrane microenvironments or
between exons 3 and 4. These ESTs do not have significant openrafts (Harder and Simons, 1999). The localization of cho-
reading frames, and we obtained no amplification by RT-PCR with
linesterase-PRiMA complexes may also depend upon primers located within these ESTs and the flanking PRiMA exons.
interactions of AChE or BChE with extracellular partners, Three ESTs (AI479806, AW893489, and AA357626) correspond to
since cholinesterases belong to a superfamily of / sequences between exons 4 and 5, in the reverse orientation. None
of these intronic ESTs correspond to alternative transcripts ofhydrolases that includes some adhesion proteins, such
PRiMA.as neuroligin and neurotactin (Botti et al., 1998), and
possesses a Ca2 binding EF-hand motif (Tsigelny et
Murine Genomic Sequenceal., 2000). In addition, the cytoplasmic region of PRiMA
Several PRiMA-containing cosmids were obtained from RZPD (Re-
possesses a cluster of basic residues close to the mem- source Center/Primary Database: Resource Center of the German
brane, which may interact with intracellular partners in Human Genome Project) by screening murine genomic libraries with
a manner which could be regulated by phosphorylation probe A (Figure 1). The noncoding region of exon 5 of PRiMA was
sequenced from clone MPMGc121L23514Q2, received from RZPD.of either S131 or S142.
Interaction with intra- or extracellular proteins may
Nucleic Acid Purificationdepend upon the neuron, since some neurons express
DNA purifications were performed with Nucleospin columns (Ma-AChE in both somatodendritic and axonal compart-
cherey-Nagel, Hoerdt, France) for genetic engineering experiments
ments whereas others do so only in the somatodendritic and with Nucleobond (Macherey-Nagel, Hoerdt, France) for trans-
compartment (Mesulam, 2000). Such interactions may fection experiments. Total RNA was extracted with RNA-PLUS
either stabilize or destabilize the enzymes on the cell buffer (Quantum, Illkirch, France) and poly-A mRNA was purified
with Oligotex Direct mRNA kit (Qiagen).surface. This opens the possibility to prevent the mem-
brane anchoring of AChE or its integration into supramo-
Production and Purification of GST Proteinslecular structures in a specific manner. Thus, the func-
GST and the PRiMA-GST fusion protein were expressed in XLI-Bluetion of AChE could be modified in the brain with little
E. coli (Novagen) for small-scale and in BL21 E. coli (Novagen) for
effect on muscles, where collagen-tailed forms repre- large-scale production. The fusion protein was purified by glutathi-
sent the predominant species. one beads chromatography (Amersham Pharmacia Biotech) ac-
cording to the manufacturer’s instructions and injected for rabbit
immunization.Experimental Procedures
Construction of cDNA Western Blots
AChE samples were incubated at 100C for 5 min in loading bufferWe found a human genomic sequence encoding the membrane
anchor in the BAC AL132642 by BLAST screening with the N-termi- (6.25% glycerol, 4% SDS, 30 mM Tris-HCl, 250 mM NaCl, and 0.01%
bromophenol blue [pH 6.8], with or without 40 mM dithiothreitolnal sequence EPQKSCSKYTD and by searching for putative splice
sites. We used the Vector NTI software to perform sequence analy- and 5% -mercapthoethanol, as indicated). The samples were then
subjected to electrophoresis in precast Tris-HCl 4%–15% linearses (Informax, Inc).
RACE experiments were performed with gene-specific-nested acrylamide gradient gels (Criterion, Bio-Rad) with 192 mM glycine,
25 mM Tris, and 0.1% SDS (pH 8.5) as the electrophoresis buffer.primers deduced from the mouse cDNA sequence. As a template,
we used RNA from neuroblastoma cells (N18TG2) that had been Protein bands were stained in the gel using SYPRO Orange (Molecu-
lar Probes) according to the manufacturer’s instructions (1:5000 ininduced to differentiate for 5 days in the presence of 2% DMSO.
The 5 and 3 RACE fragments obtained were fused and subcloned 7.5% acetic acid for 1 hr). Gel electroblotting onto Westran PVDF
transfer membranes (Schleicher & Schuell) was conducted in a Bio-into pCDNA3 and pIRES2-GFP vectors (Clontech) (GenBank acces-
sion number of the sequence of the complete mouse cDNA se- Rad Mini Trans-Blot apparatus. After transfer, blots were blocked
overnight at 4C with 5% w/v ECL blocking agent (Amersham Phar-quence is AY043275).
A putative human cDNA coding sequence was deduced from macia Biotech) in Tris-buffered saline (TBS) containing 0.1% Tween-
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20 (TBS-T) and incubated for 1 hr with 1:400 primary antibodies Cell Extracts
The surface of the cell monolayer was washed once with phosphate-raised against the GST PRiMA fusion protein. The blots were then
washed for 30 min in TBS-T, incubated with anti-rabbit IgG antibod- buffered saline (PBS), and cells were then mechanically dislodged
in PBS and centrifuged at low speed. The pellet was homogenizedies conjugated to alkaline phosphatase (Promega) (diluted 1:20,000),
and washed further for 1–2 days. The blots were then developed in extraction solution (25 mM Tris-HCl [pH 7], 10 mM MgCl2, and
2% Triton X-100) by repeated pipeting and by mixing for 30 s withwith ECF substrate (Amersham Pharmacia Biotech) and analyzed
with a fluorescence scanner (FujiFilm FLA-3000). a glass-teflon homogenizer. The extracts were clarified by centrifu-
gation (15 min at 15,000 	 g), facilitating the determination of AChE
activity by the colorimetric method of Ellman et al. (1961).
Northern Blots and RT-PCR
Northern blots were performed with the Northern Max kit (Ambion)
Tissue Extraction and Immunodepletionaccording to the manufacturer’s instructions using 5 g total RNA
of PRiMA-Bound Cholinesterasesof cells per lane. The membranes were hybridized in a rapid hybrid-
Whole brain and gastrocnemian muscles were first homogenizedization buffer (Clontech) at 50C overnight with 32P labeled by random
with a Polytron homogenizer without detergent (25 mM Tris-HCl [pHpriming (Amersham Pharmacia Biotech), corresponding to mCutA
7], 10 mM MgCl2, 20 g/ml pepstatin, and 40 g/ml leupeptin). Thecoding sequence (Perrier et al., 2000) or AChE (Legay et al., 1993).
pellet was washed once with the same buffer and was then extractedThe multitissue mouse Northern blot (reference 7762-1, Clontech)
in a detergent-containing buffer (25 mM Tris-HCl [pH 7], 10 mMwas hybridized with a DNA probe corresponding to the entire coding
MgCl2, 2% Triton X-100, 20g/ml pepstatin, and 40g/ml leupeptin).sequence of PRiMA under the same conditions.
Samples of detergent extracts containing similar AChE activitiesReverse transcription of 1g of total RNA extracted from differen-
(600 mDO/min) were incubated for 2 hr at 4C with immune ortiated and undifferentiated N18TG2 cells were performed using Om-
preimmune serum (dilution 1:50). Then, 50 l of washed Protein-Gniscript reverse transcriptase (Qiagen) for 1 hr at 37C using a
agarose gel (Sigma) was added and incubated for 1 hr at 4C. AfterPRiMA-specific primer. 1/2500 of these reactions were used to am-
a short centrifugation (5 min at 11,000 	 g), the supernatants wereplify the sequence corresponding to a 233 base pairs long coding
loaded on sucrose gradients for sedimentation analyses. Becausesequence of PRiMA by PCR (30 cycles). The amplified products
the rabbit serum contains AChE and BChE activity, the profiles werewere analyzed on 2% agarose gel.
subtracted from those obtained from parallel analyses with serum
alone.
Cell Cultures
The murine neuroblastoma cell line N18TG2 was kindly provided by Sedimentation Analyses
M. Thomasi and M. Israe¨l (Gif-sur-Yvette). The cells were maintained Sedimentation analyses of AChE forms were performed in 5%–20%
in Dulbecco’s modified Eagle’s medium (DMEM) (GIBCO) supple- (w/v) sucrose gradients containing 50 mM Tris-HCl [pH 7], 10 mM
mented with 10% decomplemented fetal bovine serum, 2 mM gluta- MgCl2, and 1% Brij-97 or 0.5% Triton X-100. The gradients were
mine, and 1 mM sodium pyruvate in a water-saturated atmosphere centrifuged at 40,000 rpm at 7C for 16 hr using a SW41 rotor (Beck-
containing 5% CO2. The cells were then mechanically dislodged and man Instruments, Fullerton, California). AChE and BChE activities
grown in tissue culture flasks (75 cm2) for 5 days without changing were assayed using the Ellman colorimetric method in the presence
the culture medium. When 2% DMSO was added to the culture of 104 M iso-OMPA or 106 M BW284c51, respectively. The reaction
medium, N18TG2 cells were induced to differentiate for 4–5 days. rate was determined from optical density readings at 414 nm. The
Cocultures of stably transfected N18TG2 and N18TG2 were ob- sedimentation coefficients were deduced by a linear relationship
tained by mixing the same number of mechanically dislodged cells between the positions of internal marker proteins, alkaline phospha-
of each type, which were then grown together without antibiotics. tase (6.1S), and -galactosidase (16S) from Escherichia coli.
Cell Surface LabelingTransfections
Transfected and control cells were cultured for 1 day (undifferenti-N18TG2 cells were transfected in 60 mm culture wells with 0.5
ated N18TG2), 4–5 days (differentiated N18TG2), or 2 days (COS)g of each DNA and 5 l of Fugene 6 (Roche) according to the
on cover slides coated with 10g/ml poly-L-ornithine in PBS at 37Cmanufacturer’s instructions. COS cells were transfected with 3–5
for 48 hr. The slides were washed in PBS and were then incubated forg of each DNA as previously described (Bon and Massoulie´, 1997).
15 min at room temperature in a serum-free blocking solutionFor stable transfection with PRiMA antisense cDNA, N18TG2 cul-
(DAKO). For fasciculin staining, the samples were incubated for 1tures were transfected with 1 g of pAMIRP-IRES2-GFP (antisense
hr at room temperature with rhodaminated-fasciculin (1 g/ml) invector) or 1 g of pIRES2-GFP (control) using 3 l of Fugene 6
Tris-buffered saline containing 0.3% bovine serum albumin. Aftertransfection reagent (Roche). Stably transfected clones were se-
washing, the slides were mounted in a glycine-containing solutionlected with 500 g/ml Geneticin for 20 days and visually checked
(Fluoprep, Biome´rieux, France). Rhodaminated-fasciculin was pre-for expression of GFP.
pared as follows: fasciculine (Sigma F4293) was labeled with tetra-Rat AChE included in pEF-Bos expression vector (Legay et al.,
methylrhodamine with a FluoReporter kit (F6163, Molecular Probes)1993) human BChE clone was a generous gift of O. Lockridge (Mas-
and purified in a Sephadex G25 column. For immunostaining ofson et al., 1993).
AChE or PRiMA, we incubated the cells with the anti-AChE poly-
clonal serum (A63; 1:300) (Marsh et al., 1984), the anti-FLAG antibody
M1 (Sigma), or the anti-MYC antibody (9E10; reference 1667149Expression in Oocytes and Measurement of Extracellular
AChE Activity Roche) (1:250). After washing, the samples were incubated in Texas-
red or FITC- coupled secondary antibodies directed against rabbitRNAs were synthesized with the Ambion mMESSAGE mMACHINE
in vitro transcription kit. Around 50 nl containing 5 ng of each mRNA or mouse IgG (1 hr at room temperature; 1:250 in Tris-buffered saline
containing 0.3% bovine serum albumin). The slides were washedwere injected into Xenopus oocytes as previously described (Krejci
et al., 1999). The molecular forms of AChE were analyzed 1–2 days and mounted in a glycine-containing solution (Fluoprep, Biome´rieux,
France).after injection.
For determination of extracellular AChE activity, oocytes were Immunolabeling with the polyclonal serum A63 produced distinct
clusters on the surface of transfected or nontransfected differenti-washed in Barth culture medium (2 days after injection). Oocytes
were placed individually in wells containing 200 l reaction medium ated cells. We obtained similar clusters by immunolabeling with
monoclonal M1 antibodies, in the case of N18TG2 cells expressing(1 mM acetylthiocholine and 1mM DTNB in Barth medium) in a 96-
well plate. The plates were incubated at room temperature under the FLAG-PRiMA construct. In contrast, the monovalent toxin fasci-
culin produced a homogenous staining of AChE at the surface ofshaking, and absorbance was measured every 10 min at 414 nm
and 550 nm. The rate of substrate hydrolysis (pmol ACh/oocyte/ undifferentiated or differentiated N18TG2 cells transfected with
PRiMA; we only observed fasciculin-labeled clusters in the case ofmin) was obtained from OD variation and standard deviation was
calculated for each pool of oocytes injected with the same mRNAs. colabeling with M1. The formation of clusters was therefore induced
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by immunoreaction with divalent antibodies directed against AChE Harder, T., and Simons, K. (1999). Clusters of glycolipid and glycosyl-
phosphatidylinositol-anchored proteins in lymphoid cells: accumu-or PRiMA.
Labeling of exogenous or endogenous membrane-bound AChE lation of actin regulated by local tyrosine phosphorylation. Eur. J.
Immunol. 29, 556–562.on N18TG2 or COS was much more intense with anti-AChE (A63)
than with fasciculine, which can be due in part to the clustering Inestrosa, N.C., Roberts, W.L., Marshall, T.L., and Rosenberry, T.L.
property of A63 antibodies. (1987). Acetylcholinesterase from bovine caudate nucleus is
attached to membranes by a novel subunit distinct from those of
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